Damora Therapeutics CFO Lori Firmani Steps Down, Effective May 1

Benzinga Newsdesk www.benzinga.com Neutral 92.8%

Neg 0% Neu 92.8% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1800315/000119312526203913/dmra-20260428.htm

Comments

No comments yet. Be the first!